Associations of self-management behaviors, depressive symptoms, and glycemic control on cognitive function in rural elderly with type 2 diabetes - Top-Institutions - MDSpire

Associations of self-management behaviors, depressive symptoms, and glycemic control on cognitive function in rural elderly with type 2 diabetes

  • By

  • Yuting Wang

  • Yating Qi

  • Zhixin An

  • Miaomiao Zhao

  • Yaqin Zhong

  • Youjia Wu

  • Qunhong Wu

  • Yuexia Gao

  • March 31, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Geriatrics
    • Neurocognitive Disorders

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Neurology
    • Geriatrics
    • Psychiatry

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Neurology
    • Geriatrics
    • Behavioral Health

  • #4

    Peking University Health Science Center
    Peking University Health Science Center

    Beijing, Beijing

    Key Differentiators

    • Endocrinology
    • Geriatrics
    • Neurology
    • Public Health

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Neurology
    • Geriatrics
    • Psychiatry

Original Source(s)

Associations of self-management behaviors, depressive symptoms, and glycemic control on cognitive function in rural elderly with type 2 diabetes

  • by Yuting Wang, Yating Qi, Zhixin An, Miaomiao Zhao, Yaqin Zhong, Youjia Wu, Qunhong Wu, Yuexia Gao

  • March 31, 2026

Related Content

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

AI Screening for Diabetic Retinopathy

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.